Roche's Polivy combination reduced the risk of disease worsening or death by 27% in ...

Retrieved on: 2021-12-15 16:55:57

Tags for this article:

Click the tags to see associated articles and topics

Roche's Polivy combination reduced the risk of disease worsening or death by 27% in .... View article details on hiswai:

Excerpt

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from the phase III POLARIX study showing that treatment with Polivy® (polatuzumab ...

Article found on: www.pharmiweb.com